The Ministry of Health, through the National Center for Strategic Health Resource Supply (Cenares), held a training session titled “Approach to Therapeutic Failure in Pharmacovigilance” for the Pharmacovigilance and Technovigilance Committee at the Regional Hospital of Lambayeque, according to a March 18 announcement.
The initiative aims to help health professionals identify problems related to medications, such as therapeutic failures, adverse reactions, or medication errors. This is intended to prevent risks and improve patient treatment outcomes.
Pharmacovigilance is described as a public health activity focused on detecting, evaluating, and preventing risks associated with medicines after they are marketed. Therapeutic failure occurs when a medicine does not produce its expected effect in a patient despite being used as intended.
The training took place on March 12 and included 15 health professionals. Participants included specialists from the Lambayeque Regional Health Management Office, members of the hospital’s Pharmacovigilance and Technovigilance Committee, and representatives from the rare diseases health strategy. The session reinforced knowledge about reporting and analyzing events linked to medication safety.
During the event, trainers discussed therapeutic failure as defined by the Pan American Health Organization: an unexpected failure of a medicine to produce its intended effect, which can affect patient recovery if not detected early. The Cenares technical team also visited the hospital pharmacy warehouse to strengthen good practices that ensure pharmaceutical product quality.
Cenares previously conducted two similar trainings: one during the National Technical Meeting on Pharmacovigilance and Technovigilance in Lima in 2025 with 50 participants, and another at the Honorio Delgado-Hideyo Noguchi National Institute of Mental Health with 12 attendees. These efforts are part of ongoing work by Cenares to promote safe use of medicines nationwide.
